Working… Menu

Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients (Convince)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01719536
Recruitment Status : Completed
First Posted : November 1, 2012
Last Update Posted : July 5, 2019
Information provided by (Responsible Party):
Betta Pharmaceuticals Co., Ltd.